Discover 2,367 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Plainfield offers many clinical trial opportunities with focuses on various conditions, including ADHD, prurigo nodularis, autoimmune diseases like lupus, and cardiovascular conditions. The city's leading institutions are actively recruiting both healthy volunteers interested in paid research options, as well as those with specific health conditions for studies that could lead to groundbreaking discoveries and improved treatments.
Filter
2
Filter results
Results: 2,367
MANAGE-AF Registry -MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)
for
Atrial Fibrillation
Location: Chicago IL
Sponsor: CorVita Science Foundation
Sex: All
Age: 18+
Code: NCT05978466
Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: Chicago IL, Iowa City IA, Louisville KY, Detroit MI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase3, Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Chicago IL, Lexington KY, Nashville TN, Baltimore MD,
Sponsor: Clasp Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06778863
Phase1, Recruiting
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
for
Metastatic Colorectal Adenocarcinoma,
Location: Chicago IL, Racine WI, Franklin WI, Wauwatosa WI,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT05673148
Phase2, Recruiting
Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer
for
HPV-Negative Squamous Cell Carcinoma
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 18+
Code: NCT06005324
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1
for
Relapsed/Refractory Acute Myeloid Leukemia
Location: Chicago IL, Grand Rapids MI, Cincinnati OH, Columbus OH,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT06714591
Phase1, Recruiting
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
for
Metastatic Colorectal Carcinoma,
Location: Chicago IL, Madison WI, Carmel IN, Grand Rapids MI,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT05863195
Phase3, Recruiting
A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
for
B-cell Acute Lymphoblastic Leukemia,
Location: Chicago IL, Buffalo NY, Boston MA
Sponsor: Marlise Luskin, MD
Sex: All
Age: 18+
Code: NCT03595917
Phase1, Recruiting
Combination Therapy for the Treatment of Diffuse Midline Gliomas
for
Diffuse Intrinsic Pontine Glioma,
Location: Chicago IL, Indianapolis IN, St Louis MO, Ann Arbor MI,
Sponsor: University of California, San Francisco
Sex: All
Age: 2 - 39
Code: NCT05009992
Phase2, Recruiting
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
for
Bladder Cancer
Location: Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 65+
Code: NCT06427824
Recruiting
CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
for
HER2-negative Breast Cancer, Metastatic Breast Cancer
Location: Chicago IL, Baltimore MD, Chapel Hill NC, Dallas TX,
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 70+
Code: NCT05029999
Phase1, Recruiting
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
for
Acute Myeloid Leukemia,
Location: Chicago IL, Cincinnati OH, West Chester OH, Columbus OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05886049
Phase1, Recruiting
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Chicago IL, St Louis MO, Ann Arbor MI, Detroit MI,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06385080
Phase1, Phase2, Recruiting
Interventions to De-implement Unnecessary Antibiotic Prescribing for Children With Ear Infections